DelistingOct 29, 2026, 05:06 PM
Glucotrack to be Delisted from Nasdaq; Plans OTC Move
AI Summary
Glucotrack, Inc. has been notified by Nasdaq of its delisting due to non-compliance with the minimum bid price rule. Despite a prior exception, the company's closing bid price fell below the required $1.00 threshold. Trading suspension on Nasdaq is set for October 30, 2026, with the company planning to move its listing to the OTC Markets Group.
Key Highlights
- Glucotrack, Inc. received notice from Nasdaq of its delisting due to failure to meet the $1.00 minimum bid price requirement.
- The company failed to satisfy the terms of an exception granted by Nasdaq, which required maintaining a closing bid price of at least $1.00 through November 9, 2026.
- Trading of Glucotrack's common stock on Nasdaq will be suspended effective October 30, 2026.
- The company expects its shares to be quoted on the OTC Markets Group (OTC) upon suspension from Nasdaq.
Price Impact
More from GCTK